Searched for
DANSSEN CONSULTING
Why MNC pharma companies are realigning their India operationsAt a time when the local market is assuming the centre stage of the growth strategy for Indian pharma companies, multinational drugmakers a...- Top three pharma MNCs Novartis, Pfizer and Abbott lose 10% in 2013Most MNCs have been facing heat due to fast expiring patents, challenges in new drug discovery and depleting product pipeline.
- Pharma MNCs run into rough weatherThe rejection of the Glivec patent has added to pharma MNCs’ woes after a slew of measures in the past one year.
- Indian Pharma Industry: In the pink of healthInnovation, international partnerships, collaborations, inflow of funds, clinical trials partnerships and co-development deals are changing...
Load More- Indian Pharma Industry: In the pink of health